Symphogen A/S of Denmark has entered into an alliance with an antibody technology provider in the US to strengthen its therapeutic antibody business which is based on developing antibody mixtures for applications in cancer. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
